HUNTERDON HUNT SETS DENTAL VENTURE YARDLEY Penn March Hunterdon Pharmaceuticals Inc said it formed a joint venture with Chesapeake Biological Laboratories and E B Michaels Research Associates to develop C G a substance that may be useful in the treatment or prevention of plaque The substance tested in pre clinical trials at the University of Pennsylvania also has other uses as an anti fungal or anti bacterial agent the company said It said Chesapeake Biological a private company owns pct of the venture E B Michaels pct while it holds the remaining interest and the patent for C G Reuter